Patho-Seq is a new combination of sequencing protocol and Ripseq technologies adapted to meet FDA’s specific requirements for approval for clinical use. Patho-Seq WILL NOT be available for sale until it has received FDA marketing approval. If you wish to use Pathogenomix’s current technologies for research-only purposes, please see the RipSeq tab.

Read our latest press release

Pathogenomix granted FDA Breakthrough Device Designation

Santa Cruz, CA: January 19th 2022: The FDA has granted Patho-Seq a Breakthrough Device Designation due to its significant advantages compared to current FDA-approved methods for the diagnosis of pathogenic bacteria in cases where infection may threaten life or long-term health.

Read more

Platform agnostic

Patho-Seq can analyze NGS direct-from-specimen sequencing files from any major hardware manufacturer. Using our novel algorithms, the total time for one analysis is less than five minutes - no matter if the sample is a pure sample or a complex poly microbial one.

Curated databases

Our Patho-Seq DB databases has the most up to date references, but without the clutter. Databases are filtered and automatically curated to ensure an ID you can rely on.

Cloud SaaS solution

Patho-Seq is always online and always updated. All you need is an internet browser. We push our new algorithms as well as new database references up to the cloud every night for your benefit.

Patho-Seq NGS - It is FAST!

Using our novel algorithms Patho-Seq will process your targeted NGS sequence file locally, and reduce the information needed to upload by a factor of 1000:1, while still retaining resolution and specificity. This means no lengthy file upload, and no costly big data file storage.

After upload, the cloud based Patho-Seq will analyze the uploaded reads against any of our curated Patho-Seq DB databases - no matter the target.

All this in less than 5 minutes! Including reporting!

Pathogenomix Patho-Seq - 5 minute NGS analysis pipeline

Patho-Seq DB - The best microbial database there is.

Pathogenomix's curated pathogen database Patho-Seq DB, extends and improves the effectiveness of the public DNA sequence databases such as GenBank and others. While GenBank contains large numbers of current references, it also has many uninformative or even erroneous references that hinder accurate identification.

To ensure the best reference quality and accuracy, Patho-Seq DB enables users to curate a more medically-relevant reference database. Users can annotate, reject and approve references using personalized methods. This on top of the solid foundation of advanced automatic filters and cross referencing makes Patho-Seq DB the database of choice.

Curated databases are a prerequisite for rapid, accurate analysis of Next Generation Sequencing (NGS) as well as Sanger data. This will ensure that the user can be confident that the analysis results are complete and accurate.

Pathogenomix Patho-Seq - Our reference database is second to none!